Development of neuroprotective compounds in the pharmaceutical industry: where are we, and where are we going?
Santilli
Nancy
N
Elan Pharmaceuticals, 800 Gateway Blvd, South San Francisco, CA 94080, USA. Nancy.Santilli@elan.com
D000818:Animals; D002493:Central Nervous System Diseases / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004345:Drug Industry / Q000639:trends; D004827:Epilepsy / Q000188:drug therapy*; D006801:Humans; D018696:Neuroprotective Agents / Q000138:chemical synthesis / Q000627:therapeutic use*; D012449:Safety
D018696:Neuroprotective Agents